KB
Kalpesh Bhavarlal Mehta
About Kalpesh Bhavarlal Mehta
Data last updated:
Kalpesh Bhavarlal Mehta is a Designated Partner at Shray Pharma Llp (since 2019), Director at Vitalone Pharma Private Limited (since 2024) and Director at Hestco Healthcare Private Limited (since 2023). The companies operate in Pharma and Paper. The largest current company by reported revenue is Shray Pharma Llp at ₹38.7 Lakh (FY 2022). Earlier, Kalpesh Bhavarlal Mehta was a Director at Exemplus Healthcare Private Limited (2024–2025) and Director at Lebron Lifesciences Private Limited (2023–2025) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shray Pharma Llp AAQ-0576 | Designated Partner | 25 Jul 2019 | 2019 | ₹38.7 Lakh (FY 2022) | Active |
| Vitalone Pharma Private Limited U21001MH2024PTC417146 | Director | 12 Jan 2024 | 2024 | Active | |
| Hestco Healthcare Private Limited U21000MH2023PTC413936 | Director | 18 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Exemplus Healthcare Private Limited U21001MH2024PTC416536 | Director | 02 Jan 2024 | 2024 | Active | |
| Lebron Lifesciences Private Limited U46497MH2023PTC416039 | Director | 26 Dec 2023 | 2023 | Active | |
| Rrakov Pharmaceuticals Llp AAK-4992 | Designated Partner | 05 Sep 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kalpesh Bhavarlal Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kamlesh Harish Jain | 02851812 | Shray Pharma Llp | Designated Partner |
| Rajani Kalpesh Mehta | 07902796 | Shray Pharma Llp | Designated Partner |
| Ritesh Jain Harish | 02613819 | Shray Pharma Llp | Designated Partner |
| Roshan Lalchand Jain | 05250390 | Shray Pharma Llp | Designated Partner |
| Sanjay Suresh Jain | 00606137 | Vitalone Pharma Private Limited , Hestco Healthcare Private Limited | Director |
| Subhir Navinchandra Shah | 06403764 | Vitalone Pharma Private Limited , Hestco Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalpesh Bhavarlal Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalpesh Bhavarlal Mehta
Kalpesh Bhavarlal Mehta currently holds 3 directorships: Shray Pharma Llp (Designated Partner, since 25 Jul 2019, revenue ₹38.7 Lakh (FY 2022)); Vitalone Pharma Private Limited (Director, since 12 Jan 2024); Hestco Healthcare Private Limited (Director, since 18 Nov 2023).
Kalpesh Bhavarlal Mehta was first appointed on 05 Sep 2017 as Designated Partner at Rrakov Pharmaceuticals Llp. The most recent appointment on record is 12 Jan 2024 at Vitalone Pharma Private Limited.
Kalpesh Bhavarlal Mehta held 3 earlier board appointments: Exemplus Healthcare Private Limited (Director, 02 Jan 2024 to 01 Feb 2025); Lebron Lifesciences Private Limited (Director, 26 Dec 2023 to 01 Feb 2025); Rrakov Pharmaceuticals Llp (Designated Partner, from 05 Sep 2017).
The current boards of Kalpesh Bhavarlal Mehta's companies include Kamlesh Harish Jain (Shray Pharma Llp), Rajani Kalpesh Mehta (Shray Pharma Llp), Ritesh Jain Harish (Shray Pharma Llp), Roshan Lalchand Jain (Shray Pharma Llp), Sanjay Suresh Jain (Vitalone Pharma Private Limited), Subhir Navinchandra Shah (Vitalone Pharma Private Limited).